Glucotrack CFO James Cardwell resigns; Peter Wulff appointed as CFO

Glucotrack, Inc.

James Cardwell resigned as CFO effective Jan 27, 2025; will remain as consultant for transition.
Peter Wulff appointed CFO effective Jan 28, 2025; has 40+ years life sciences finance experience.
Wulff's base salary: $300k for 2025, $450k thereafter; eligible for bonuses tied to financing milestones up to $262.5k total.
Initial equity grant of options for 1.25% of outstanding common stock under 2024 Equity Incentive Plan.
Wulff most recently CFO at Biological Dynamics; previously CFO at JenaValve Technology.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

James Cardwell

Chief Financial Officer

GCTK · Glucotrack, Inc.

Effective: 2025-01-27
Successor: Peter C. Wulff
Filed: January 29, 2025, 6:59 PM ET

On January 27, 2025, James Cardwell informed the Board of Directors (the “Board”) of Glucotrack, Inc. (the “Company”) that he was resigning as Chief Financial Officer of the Company, effective immediately.

Appointed

Peter C. Wulff

Chief Financial Officer

GCTK · Glucotrack, Inc.

Effective: 2025-01-28
Filed: January 29, 2025, 6:59 PM ET

In connection with Mr. Cardwell’s resignation, on January 28, 2025, the Board appointed Peter C. Wulff as Chief Financial Officer of the Company.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

James Cardwell resigned as Chief Financial Officer at Glucotrack, Inc..

Action: resigned
Role: Chief Financial Officer

Exact text from the filing

On January 27, 2025, James Cardwell informed the Board of Directors (the “Board”) of Glucotrack, Inc. (the “Company”) that he was resigning as Chief Financial Officer of the Company, effective immediately.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Peter C. Wulff was appointed as Chief Financial Officer at Glucotrack, Inc..

Action: appointed
Role: Chief Financial Officer

Exact text from the filing

In connection with Mr. Cardwell’s resignation, on January 28, 2025, the Board appointed Peter C. Wulff as Chief Financial Officer of the Company.

View on SEC.gov

Glucotrack, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-25-004104

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.